A Distinct Metabolite Signature in Military Personnel Exposed to Repetitive Low-Level Blasts.
biomarkers
blast
metabolites
mild traumatic brain injury
military
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2022
2022
Historique:
received:
08
12
2021
accepted:
10
03
2022
entrez:
25
4
2022
pubmed:
26
4
2022
medline:
26
4
2022
Statut:
epublish
Résumé
Military Breachers and Range Staff (MBRS) are subjected to repeated sub-concussive blasts, and they often report symptoms that are consistent with a mild traumatic brain injury (mTBI). Biomarkers of blast injury would potentially aid blast injury diagnosis, surveillance and avoidance. Our objective was to identify plasma metabolite biomarkers in military personnel that were exposed to repeated low-level or sub-concussive blast overpressure. A total of 37 military members were enrolled (18 MBRS and 19 controls), with MBRS having participated in 8-20 breaching courses per year, with a maximum exposure of 6 blasts per day. The two cohorts were similar except that the number of blast exposures were significantly higher in the MBRS, and the MBRS cohort suffered significantly more post-concussive symptoms and poorer health on assessment. Metabolomics profiling demonstrated significant differences between groups with 74% MBRS classification accuracy (CA). Feature reduction identified 6 metabolites that resulted in a MBRS CA of 98%, and included acetic acid (23.7%), formate (22.6%), creatine (14.8%), acetone (14.2%), methanol (12,7%), and glutamic acid (12.0%). All 6 metabolites were examined with individual receiver operating characteristic (ROC) curve analyses and demonstrated areas-under-the-curve (AUCs) of 0.82-0.91 (
Identifiants
pubmed: 35463119
doi: 10.3389/fneur.2022.831792
pmc: PMC9021419
doi:
Types de publication
Journal Article
Langues
eng
Pagination
831792Informations de copyright
Copyright © 2022 Her Majesty the Queen in Right of Canada.
Déclaration de conflit d'intérêts
DF discloses a provisional patent and the licensing of technology to Neurolytixs Inc., a diagnostics biotechnology company that is focused on mild traumatic brain injury (www.neurolytixs.com). AD and DF are members of Neurolytixs Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Neurosci Res. 1997 Apr;27(4):317-22
pubmed: 9152044
Mil Med. 2021 Jan 30;186(3-4):e393-e400
pubmed: 33135742
Neuroscience. 2009 Jan 12;158(1):301-8
pubmed: 18423998
Front Neurol. 2020 Dec 03;11:588531
pubmed: 33343492
Nutrients. 2021 Feb 10;13(2):
pubmed: 33578876
Br J Surg. 1989 Oct;76(10):1006-10
pubmed: 2597940
Magnes Res. 1995 Sep;8(3):249-59
pubmed: 8845290
Front Neurol. 2021 Mar 10;12:628782
pubmed: 33776888
J Neurotrauma. 2021 Jun 15;38(12):1608-1614
pubmed: 33176582
Brain Res Bull. 2008 Jul 1;76(4):329-43
pubmed: 18502307
Crit Care Explor. 2020 Oct 21;2(10):e0272
pubmed: 33134953
Front Neurol. 2019 Aug 16;10:875
pubmed: 31474930
Mil Med. 2018 Mar 1;183(suppl_1):28-33
pubmed: 29635591
Clin Rehabil. 2005 Dec;19(8):878-87
pubmed: 16323387
J Int Neuropsychol Soc. 2013 Jan;19(1):1-10
pubmed: 23095177
Assessment. 2015 Jun;22(3):289-97
pubmed: 25178804
J Pharm Biomed Anal. 2015 Sep 10;113:108-20
pubmed: 25577715
J Spec Oper Med. 2020 Spring;20(1):87-93
pubmed: 32203612
J Neurosci Res. 2010 Dec;88(16):3530-9
pubmed: 20882564
Neurobiol Dis. 2011 Feb;41(2):538-51
pubmed: 21074615
Crit Rev Food Sci Nutr. 2016 Jul 29;56 Suppl 1:S171-5
pubmed: 26176799
J Neurol. 1995 Sep;242(9):587-92
pubmed: 8551320
Metabolites. 2018 Sep 07;8(3):
pubmed: 30205491
J Exp Neurosci. 2019 Sep 12;13:1179069519872213
pubmed: 31548796
Pathophysiology. 2001 Dec;8(2):105-111
pubmed: 11720806
J Trauma. 1996 Mar;40(3 Suppl):S100-4
pubmed: 8606388
JAMA Netw Open. 2021 Apr 1;4(4):e216445
pubmed: 33861330
Brain Inj. 2020 Jul 28;34(9):1213-1221
pubmed: 32755419
Clin Chem Lab Med. 2013 Mar 1;51(3):571-8
pubmed: 23241677
J Neural Transm (Vienna). 2014 Aug;121(8):799-817
pubmed: 24578174
BMC Psychiatry. 2014 Nov 20;14:325
pubmed: 25410348
Med Care. 1992 Jun;30(6):473-83
pubmed: 1593914
Amino Acids. 2010 Jan;38(1):31-44
pubmed: 19253023
J R Army Med Corps. 2019 Feb;165(1):38-40
pubmed: 29643122
Mil Med. 2016 May;181(5 Suppl):28-39
pubmed: 27168550
J Acad Nutr Diet. 2021 May;121(5):895-914
pubmed: 33436350
J Neurotrauma. 2020 Apr 15;37(8):1091-1096
pubmed: 31642374
Mol Metab. 2020 Mar;33:23-37
pubmed: 31402327
Sci Transl Med. 2019 Feb 20;11(480):
pubmed: 30787166
J Head Trauma Rehabil. 2009 Jan-Feb;24(1):14-23
pubmed: 19158592
Neuropathol Appl Neurobiol. 1995 Oct;21(5):369-77
pubmed: 8632831
Mil Med. 2022 Jan 4;187(1-2):e201-e208
pubmed: 33492379
Eur J Clin Nutr. 2015 Jun;69(6):734-9
pubmed: 25626409
Front Neurol. 2019 Jun 12;10:585
pubmed: 31244753
Physiol Rev. 2013 Oct;93(4):1621-57
pubmed: 24137018